China
# |
Name |
Net Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
32.44%
|
Dec. 31, 2023 | USD 2.32 | 0.60% |
|
China |
|
2 |
27.42%
|
Dec. 31, 2023 | USD 3.78 | 2.83% |
|
China |
|
3 |
25.47%
|
Dec. 31, 2023 | USD 0.46 | -14.39% |
|
China |
|
4 |
19.82%
|
Dec. 31, 2023 | USD 0.83 | 0.19% |
|
China |
|
5 |
12.77%
|
Dec. 31, 2023 | USD 0.31 | 1.75% |
|
China |
|
6 |
5.59%
|
Dec. 31, 2023 | USD 1.42 | 0.22% |
|
China |
|
7 |
-4.84%
|
Dec. 31, 2023 | USD 0.22 | -3.92% |
|
China |
|
8 |
-11.37%
|
Dec. 31, 2023 | USD 1.39 | -0.51% |
|
China |
|
9 |
-11.47%
|
Dec. 31, 2023 | USD 0.65 | -3.74% |
|
China |
|
10 |
-14.38%
|
Dec. 31, 2023 | USD 0.50 | 0.55% |
|
China |
|
11 |
-53.42%
|
Dec. 31, 2023 | USD 0.99 | 0.17% |
|
China |
|
12 |
-66.98%
|
Dec. 31, 2023 | USD 2.51 | -1.95% |
|
China |
|
13 |
-79.17%
|
Dec. 31, 2023 | USD 0.30 | 3.10% |
|
China |
|
14 |
-85.47%
|
Dec. 31, 2023 | USD 0.74 | -0.48% |
|
China |
|
15 |
-96.26%
|
Dec. 31, 2023 | USD 0.46 | 4.36% |
|
China |
|
16 |
-101.49%
|
Dec. 31, 2023 | USD 4.06 | -0.12% |
|
China |
|
17 |
-104.61%
|
Dec. 31, 2023 | USD 1.90 | 2.70% |
|
China |
|
18 |
-109.56%
|
Dec. 31, 2023 | USD 0.76 | 1.59% |
|
China |
|
19 |
-121.63%
|
Dec. 31, 2023 | USD 6.68 | -1.47% |
|
China |
|
20 |
-125.46%
|
Dec. 31, 2023 | USD 2.78 | -0.65% |
|
China |
|
21 |
-140.43%
|
Dec. 31, 2023 | USD 1.86 | 4.07% |
|
China |
|
22 |
-151.85%
|
Dec. 31, 2023 | USD 1.48 | -0.31% |
|
China |
|
23 |
-255.70%
|
Dec. 31, 2023 | USD 0.54 | 4.27% |
|
China |
|
24 |
-416.98%
|
Dec. 31, 2023 | USD 4.76 | 1.54% |
|
China |
|
25 |
-429.55%
|
Dec. 31, 2023 | USD 3.86 | 0.37% |
|
China |
|
26 |
-565.36%
|
Dec. 31, 2023 | USD 0.20 | 3.31% |
|
China |
The Vaccines company in China with the highest Net Income Margin is Hansoh Pharmaceutical Group Company Limited (HKSE: 3692.HK) at 32.44%.
The Vaccines company in China with the lowest Net Income Margin is Jacobio Pharmaceuticals Group Co., Ltd. (HKSE: 1167.HK) at -565.36%.
The top 10 Vaccines companies in China by Net Income Margin are Hansoh Pharmaceutical Group Company Limited, Hangzhou Tigermed Consulting Co., Ltd., HBM Holdings Limited, 3SBio Inc., Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., China Isotope & Radiation Corporation, TOT BIOPHARM International Company Limited, Genscript Biotech Corporation, Yunkang Group Limited and Shenzhen Hepalink Pharmaceutical Group Co., Ltd..
The bottom 10 Vaccines companies in China by Net Income Margin are Jacobio Pharmaceuticals Group Co., Ltd., CanSino Biologics Inc., Ascentage Pharma Group International, Ascletis Pharma Inc., Shanghai Junshi Biosciences Co., Ltd., RemeGen Co., Ltd., Zai Lab Limited, Burning Rock Biotech Limited, AIM Vaccine Co., Ltd. and Adagene Inc..